TARGETED SENOLYTIC STRATEGIES
IN THE NEWS
Rubedo collaborates with Cedars-Sinai on senolytic IPF program
Senolytic start-up establishes collaboration with Cedars-Sinai Medical Center to advance idiopathic pulmonary fibrosis program.
- Published: 7:17 am
Venture Capitalists Back Biotech Push to Combat Aging
- Published: 4:53 pm
News briefing: New senescent cell play launches with $12M
- Published: 4:05 pm
Rubedo Life Sciences Closes $12M Seed Financing Led by Khosla Ventures
- Published: 3:32 pm
Rubedo featured among top senolytic companies in Nature Biotechnology
Send in the senolytics
Despite early failures in the clinic, the idea of anti-aging therapies that purge the body of dying cells is gaining traction with a raft of startups now focused on senescence.
Valuable review describing the emerging field of therapeutic development targeting senescence biology to treat age-related conditions.
- Published: 8:20 pm
Rubedo at Longevity Therapeutics Conference 2021
Join us at LT2021. Rubedo will be contributing with a lecture and a round table.
Rubedo Life Sciences CEO, Dr. Marco Quarta, will be Chairman of the Conference
on Day 1 – he will join the Panel Discussion titled
A Therapeutic Revolution Against Aging – Bridging the Gaps & Opportunities
On Day 2 – Dr. Quarta will give a lecture on
Higher selectivity and safety of Targeted Senolytcs
- Published: 9:48 pm
Internship Opportunities in 2021 at Rubedo
Salaried internship opportunities at Rubedo Life Sciences for 2021-2022
9 month internship – CalPoly CIRM Master Program for Regenerative Medicine
Summer Internship – SENS Research Foundation Program
- Published: 2:11 am
Another New Senolytic Prodrug is Demonstrated to Reverse Frailty and Loss of Cognitive Function in Old Mice
- Published: 2:00 am
Silicon Valley, CA, USA
Copyright 2020 by Rubedo Life Sciences, inc